Drug Database
Back to search

Belgium· BE-AMP-SAM111456-00

Sufenta Forte 50 µg/ml

A sufentanil product containing sufentanil citrate, registered in Belgium by Piramal Critical Care. The same ATC class is registered in 11 of our 19 countries.

ATC N01AH03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedSufenta Forte 50 µg/mlATCN01AH03REGISTER NO.BE-AMP-SAM111456-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sufentanil citrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sufentanil is registered in 11 of 19 countries.

Countries holding a registration under ATC N01AH03 (sufentanil), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search sufentanil products by name

Sufentanil · ATC N01AH03

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Sufentanil Citrate
Manufacturer
Piramal Critical Care
Country
Belgium (BE)
ATC code
N01AH03
ATC class
Sufentanil
Defined daily dose
30 mcg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0291930
  • be_apb
    0718072

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

216 interactions on record for sufentanil.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check sufentanil against other medicinesHow interaction checks work

Sufentanil · interactions on record

216 records

  • 20 severe
  • 158 moderate
  • 38 info

Most severe, free to view

  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • PalonosetronA04AA05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sufentanil in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sufentanil products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Sufenta, Sufentanil Hameln
  • Cyprus · Sofentil
  • Czechia · Sontilen, Sufenta
  • Germany · Sufenta, Sufenta Epidural
  • Denmark · Sofentil, Sufenta
  • Spain · Safentil, Secufen
  • Finland · Sufenta, Sufenta Forte
  • France · Sufenta, Sufentanil Renaudin
  • United Kingdom (Northern Ireland) · Dzuveo
  • Croatia · Sofentil, Sufentanil Altamedics
  • Hungary · Sufentanil Hameln, Sufentanil Torrex
  • Iceland · Dzuveo, Sufenta
  • Italy · Disufen, Sufentanil Hameln
  • Liechtenstein · Dzuveo, Sufenta
  • Luxembourg · Sufenta, Sufenta Forte
  • Latvia · Sontilen
  • Malta · Sofentil
  • Netherlands · Narcomed, Sufenta
  • Norway · Dzuveo, Sufenta
  • Poland · Sufentanil Chiesi, Sufentanil Hameln
  • Portugal · Sontilen, Sufenta
  • Romania · Sofentil
  • Sweden · Sufenta, Sufentanil Hameln
  • Slovenia · Sufentanil Hameln
  • Slovakia · Sofentil, Sufentanil Chiesi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3ea44194-c7e8-42e8-b6e1-0c683275cce0
GET /v1/drugs/3ea44194-c7e8-42e8-b6e1-0c683275cce0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Sufenta Forte 50 µg/ml",
  "name_fr": "Sufenta Forte 50 µg/ml",
  "name_nl": "Sufenta Forte 50 µg/ml",
  "amp_code": "SAM111456-00",
  "strengths": [
    "75.0000",
    "50.0000",
    "45.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Sufentanil Citrate",
    "Sufentanil",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Sufentanil",
  "authorisation_numbers": [
    "BE111456"
  ]
}
API referenceMCP serverPlans

See everything about sufentanil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console